Uday R Popat

81PUBLICATIONS
435CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (81)

|Oct 23, 2026
CD8 T-cell exhaustion linked with CAR T-cell failure can be mitigated by a non-alpha IL2 receptor agonist.

|Sep 27, 2026
Real-world outcomes of nivolumab-AVD and brentuximab vedotin-AVD in paediatric and adult advanced-stage Hodgkin lymphoma.

|Sep 24, 2026
Phase 1, open-label, multicenter study of sovleplenib (HMPL-523) in patients with relapsed or refractory lymphoma.

|Aug 20, 2026
Second-line CD19 CAR T vs platinum salvage and autologous stem cell transplant for primary mediastinal B-cell lymphoma.

|Jul 31, 2026
Phase 1/2 trial of Evomela for autologous transplant in myeloma: schedule optimization and matched comparison with MEL200.

|Jul 29, 2026
Impact of EBV status and histology on patient outcomes with nivolumab-AVD vs BV-AVD in advanced classic Hodgkin lymphoma (S1826).

Pageof 14

Frequent Collaborators

18 joint publications

Sattva S Neelapu

15 joint publications

Jason Westin

14 joint publications

Mehdi Hamadani

11 joint publications

Raphael Steiner